Clinical trial

Low Dose Niacin (Vitamin B3) for Parkinson's Disease

NCT03808961

StatusTERMINATED
Study typeINTERVENTIONAL
Start date2020-01-01
PhaseNA

Study timeline

Study start (actual)2020-01-01Date precision: day
Registry last updated2025-03-04
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.